Biomax announces early adopter program for NeuroXM
https://www.biomax.com/lib/press-releases/201806_NeuroXM.pdf Read more
https://www.biomax.com/lib/press-releases/201806_NeuroXM.pdf Read more
AUSTIN, Texas, June 13, 2018 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced the company recently began clinical studies for the Gastrointestinal (GI) Assay on the VERIGENE® II System, its new sample to answer benchtop molecular diagnostic system in development. The VERIGENE System enables clinicians to rapidly identify the pathogens responsible for some of the... Read more
Agilent Companion Diagnostic Gains Expanded FDA Approval in Cervical Cancer PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify cervical cancer patients for treatment with KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., June 12, 2018 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its... Read more
JUNE 7, 2018 • NEWS Advanced Instruments Announces New, Modern Logo Modern font coupled with iconic curve captures company’s legacy and strong focus on innovation NORWOOD, MA- June 7, 2018: Advanced Instruments—a leading developer of scientific and analytical instruments for the clinical, biopharmaceutical, and food-and-beverage industries—unveiled a new, modernized version of its company logo today.... Read more
Joint offering enables acceleration of genomic panel design for translational and clinical disease research SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease research. The rapidly expanding knowledge base of genes and... Read more
– Improved IR Biotyper™ system for fast, routine and cost-effective strain typing for hospital infection control and earlier detection of outbreaks – FDA clearance for Candida auris identification with the MALDI Biotyper® to support better diagnostics and monitoring in critically ill patients ATLANTA, June 7, 2018 /PRNewswire/ — At the American Society for Microbiology (ASM) Microbe... Read more
Download as PDF JUNE 07, 2018 MINNEAPOLIS, June 7, 2018 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of QT Holdings Corporation d/b/a Quad Technologies. The transaction is expected to close in early July and to be financed through available cash on hand. “We are... Read more
Basel, 05 June 2018 Save the date: Roche Analyst Event on Diagnostics Division at AACC 2018 Tuesday, 31st July 2018 We are pleased to invite you to an analyst event on Tuesday, 31st July 2018 to discuss Roche’s Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab... Read more
Modern blood tests such as QuantiFERON-TB now recommended for patients ages 2 to 18 Germantown, Maryland, and Hilden, Germany, June 4, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes new guidelines from the American Academy of Pediatrics (AAP) that recommend screening at-risk children as young as two years old... Read more
MILFORD, Mass.–(BUSINESS WIRE)– Waters (NYSE:WAT) is giving scientists attending ASMS 2018 a first look at new mass spectrometry technologies developed to serve the multi-faceted analytical requirements of food testing, university and biomedical research laboratories. The new products include a gas chromatography-mass spectrometry/mass spectrometry (GC-MS/MS) system for food safety analyses and a direct-analysis mass spectrometry system... Read more